Cross Country Healthcare (NASDAQ:CCRN) Updates Q4 2024 Earnings Guidance

Cross Country Healthcare (NASDAQ:CCRN) issued an update on its fourth quarter 2024 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.100-0.140 for the period, compared to the consensus estimate of 0.130. The company issued revenue guidance of $300.0 million-$310.0 million, compared to the consensus revenue estimate of $319.1 million. Cross Country Healthcare also updated its Q4 guidance to $0.10-$0.14 EPS.

Cross Country Healthcare Stock Performance

Shares of CCRN traded down $1.91 during mid-day trading on Friday, hitting $10.36. 1,046,631 shares of the company were exchanged, compared to its average volume of 719,060. The stock has a market cap of $350.27 million, a price-to-earnings ratio of -207.16, a price-to-earnings-growth ratio of 2.35 and a beta of 0.65. Cross Country Healthcare has a 1-year low of $10.35 and a 1-year high of $23.64. The company has a 50 day moving average of $12.94 and a 200-day moving average of $14.32.

Cross Country Healthcare (NASDAQ:CCRN) last announced its earnings results on Wednesday, November 6th. The business services provider reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.02. The business had revenue of $315.12 million during the quarter, compared to analysts’ expectations of $310.05 million. Cross Country Healthcare had a positive return on equity of 5.27% and a negative net margin of 0.12%. Research analysts anticipate that Cross Country Healthcare will post 0.52 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Truist Financial dropped their target price on shares of Cross Country Healthcare from $17.00 to $15.00 and set a “hold” rating for the company in a report on Monday, October 21st. Benchmark lowered their price target on shares of Cross Country Healthcare from $19.00 to $18.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, Barrington Research cut their price objective on shares of Cross Country Healthcare from $21.00 to $19.00 and set an “outperform” rating for the company in a report on Thursday, August 8th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Cross Country Healthcare has an average rating of “Hold” and an average target price of $18.50.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.